|
|
Volumn 63, Issue 5, 2010, Pages 769-774
|
|
Intermittent etanercept therapy in pediatric patients with psoriasis
a
|
|
Author keywords
etanercept; intermittent therapy; pediatric plaque psoriasis
|
|
Indexed keywords
ETANERCEPT;
PLACEBO;
ADOLESCENT;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED HEADACHE;
DRUG INTERMITTENT THERAPY;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
INJECTION SITE REACTION;
MAJOR CLINICAL STUDY;
MALE;
PHYSICIAN GLOBAL ASSESSMENT;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
PSORIASIS SEVERITY INDEX;
PSORIASIS VULGARIS;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RETREATMENT;
RHINOPHARYNGITIS;
SCHOOL CHILD;
SINUSITIS;
UPPER RESPIRATORY TRACT INFECTION;
ADOLESCENT;
CHILD;
CHILD, PRESCHOOL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
PSORIASIS;
RECEPTORS, TUMOR NECROSIS FACTOR;
SEVERITY OF ILLNESS INDEX;
SKIN;
SUBSTANCE WITHDRAWAL SYNDROME;
TREATMENT OUTCOME;
|
|
EID: 77957978331
PISSN: 01909622
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jaad.2009.10.046 Document Type: Article |
|
Times cited : (40)
|
|
References (7)
|
